134
Views
8
CrossRef citations to date
0
Altmetric
Regular Articles

The Multiple Bottle Effect Is Overridden in Male and Female Rats by Simultaneous Presentation of Two Oral Nicotine Solutions

, M.Sc., , B.S. & , Ph.D.
Pages 161-167 | Published online: 30 May 2013

References

  • Rose JE, Herskovic JE, Trilling Y, Jarvik ME. Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther 1985; 38(4):450–456.
  • Schneider NG, Jarvik ME, Forsythe AB. Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 1984; 9(2):149–156.
  • Martinet Y, Bohadana A, Fagerstrom K. Introducing oral tobacco for tobacco harm reduction: What are the main obstacles? Harm Reduct J 2007; 4:17.
  • Martinet Y, Bohadana A, Fagerstrom K. Would alternate tobacco products be better than smoking? Lung Cancer 2006; 53:1–4.
  • Hatsukami DK, Jensen J, Anderson A, Broadbent B, Allen S, Zhang Y, Severson H. Oral tobacco products: Preference and effects among smokers. Drug Alcohol Depend 2011; 118(2–3):230–236.
  • Schneider T, Bizarro L, Asherson PJ, Stolerman IP. Gestational exposure to nicotine in drinking water: Teratogenic effects and methodological issues. Behav Pharmacol 2010; 21(3):206–216.
  • Collins AC, Pogun S, Nesil T, Lutfiye K. Oral nicotine self-administration in rodents. Addict Res Ther 2012; S2(004):1–10.
  • Peters DA, Tang S. Sex-dependent biological changes following prenatal nicotine exposure in the rat. Pharmacol Biochem Behav 1982; 17(5):1077–1082.
  • Maehler R, Dadmarz M, Vogel WH. Determinants of the voluntary consumption of nicotine by rats. Neuropsychobiology 2000; 41(4):200–204.
  • Balfour DJ. Studies on the biochemical and behavioral effects of oral nicotine. Arch Int Pharmacodyn Ther 1980; 245:95–103.
  • Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 2007; 190(3):269–319.
  • Galli G, Wolffgramm J. Long-term development of excessive and inflexible nicotine taking by rats, effects of a novel treatment approach. Behav Brain Res 2011; 217(2):261–270.
  • Dadmarz M, Vogel WH. Individual self-administration of nicotine by rats. Pharmacol Biochem Behav 2003; 76(3–4):425–432.
  • Flynn FW, Webster M, Ksir C. Chronic voluntary nicotine drinking enhances nicotine palatability in rats. Behav Neurosci 1989; 103(2):356–364.
  • Biondolillo KD, Pearce AR. Availability influences initial and continued ingestion of nicotine by adolescent female rats. Neuropsychobiology 2007; 55(2):73–80.
  • Smith A, Roberts DC. Oral self-administration of sweetened nicotine solutions by rats. Psychopharmacology (Berl) 1995; 120(3):341–346.
  • Le Houezec J, Martin C, Cohen C, Molimard R. Failure of behavioral dependence induction and oral nicotine bioavailability in rats. Physiol Behav 1989; 45(1):103–108.
  • Lang W, Latiff A, Mcqueen A, Singer G. Self administration of nicotine with and without a food delivery schedule. Pharmacol Biochem Behav 1977; 7:65–70.
  • Biondolillo KD, Pearce AR, Louder MC, McMickle A. Solution concentration influences voluntary consumption of nicotine under multiple bottle conditions. Pharmacol Biochem Behav 2009; 92(2):214–218.
  • Benowitz NL, Porchet H, Peyton JI. Pharmacokinetics, Metabolism, and Pharmacodynamics of Nicotine: Nicotine Psychopharmacology; Molecular, Cellular and Behavioral Aspects. New York: Oxford University Press, 1990; 112–157.
  • Kim KY, Lee Y-J, Chung BC, Hong J, Jung BH. Relations between toxicity and altered tissue distribution and urinary excretion of nicotine, cotinine, and hydroxycotinine after chronic oral administration of nicotine in rats. Drug Chem Toxicol 2010; 33(2):166–172.
  • Wielkoszynski T, Tyrpien K, Szumska M. The enzyme-linked immunosorbent assay (ELISA) method for nicotine metabolites determination in biological fluids. J Pharmaceut Biomed Anal 2009; 49:1256–1260.
  • Ziegler UE, Kauczok J, Dietz UA, Reith HB, Schmidt K. Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay. Pharmacology 2004; 72(4):254–259.
  • AL-Bayaty FH, Baharuddin NA, Mahmood AA. The relationship between serum cotinine levels & periodontal status. Online J Biol Sci 2010; 10(2):54–59.
  • Miller EI, Norris HR, Rollins DE, Tiffany ST, Moore CM, Vincent MJ, Agrawal A, Wilkins DG. Identification and quantification of nicotine biomarkers in human oral fluid from individuals receiving low-dose transdermal nicotine: A preliminary study. J Anal Toxicol 2010; 34(7):357–366.
  • Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users. Addict Behav 2004; 29:349–355.
  • Klein LC, Stine MM, Vanderbergh DH, Whetzel CA, Kamons HM. Sex differences in voluntary oral nicotine consumption by adolescent mice: A dose-response experiment. Pharmacol Biochem Behav 2004; 78:13–25.
  • Boyett KB, Pearce AR, Biondolillo KD. Individual differences in voluntary self-administration of oral nicotine in female rats. Psi Chi J 2007; 12(4):162–169.
  • Lee M, Chen K, Shih JC, Hiroi M. MAO-B knockout mice exhibit deficit in activation of locomotor activity but normal nicotine intake. Genes Brain Behav 2004; 3:216–227.
  • Kaufman S. A comparison of the dipsogenic responses of male and female rats to a variety of stimuli. Can J Physiol Pharmacol 1980; 58(10):1180–1183.
  • Krause EG, Curtis KS, Davis LM, Stowe JR, Contreras RJ. Estrogen influences stimulated water intake by ovariectomized female rats. Physiol Behav 2003; 79(2):267–274.
  • Shiffman S. Tobacco “chippers” – Individual differences in tobacco dependence. Psychopharmacology (Berl) 1989; 97(4):539–547.
  • Shiffman S. Refining models of dependence: Variations across persons and situations. Br J Addict 1991; 86(5):611–615.
  • Benowitz NL, Jacob P 3rd. Individual differences in nicotine kinetics and metabolism in humans. NIDA Res Monogr 1997; 173:48–64.
  • Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009; 192:29–60.
  • Rowell PP, Hurst HE, Marlowe C, Bennett BD. Oral administration of nicotine: Its uptake and distribution after chronic administration to mice. J Pharmacol Methods 1983; 9(4):249–261.
  • Rotenberg KS, Adir J. Pharmacokinetics of nicotine in rats after multiple-cigarette smoke exposure. Toxicol Appl Pharmacol 1983; 69(1):1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.